article

PAT supplement 2011

Posted: 15 December 2011 | | No comments yet

In this PAT supplement: The historical development of the FDA’s PAT initiative and its present course; Implementation of modelling approaches in the QbD framework: Examples from the Novartis experience; Challenges in development and implementation of spectroscopic techniques as PAT Analysers…

PAT supplement 2011
  • The historical development of the FDA’s PAT initiative and its present course
    (Terry McMahon, PAI Partners)
  • Implementation of modelling approaches in the QbD framework: Examples from the Novartis experience
    (Dr. Marianna Machin, Dr. Lorenz Liesum and Dr. Antonio Peinado, Novartis Pharma AG)
  • Challenges in development and implementation of spectroscopic techniques as PAT Analysers
    (Ravindra Dhumal and Tim Gough, Centre for Pharmaceutical Engineering Science, University of Bradford)

This PAT supplement is restricted - login or subscribe free to access

Issue 6 2018 magazine coverThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • bi-monthly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here

 

Send this to a friend